Expression of this CD44 variant maintains the epithelial phenotype (Huang et al., 2017), indicating a direct connection between G4-mediated alternative splicing regulatory mechanism and phenotypic plasticity during EMT in cancer (Figure 1). The gene discussed is CD44; the disease is cancer.